These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2121014)

  • 1. Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty.
    Gurbel PA; Davidson CJ; Ohman EM; Smith JE; Stack RS
    Am J Cardiol; 1990 Oct; 66(12):1021-3. PubMed ID: 2121014
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA; Muller DW; Topol EJ
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early occlusion of the infarct-related artery after emergency PTCA for acute myocardial infarction].
    Shirotani M; Yui Y; Hattori R; Kawai C
    Jpn Circ J; 1992; 56 Suppl 5():1421-4. PubMed ID: 1291734
    [No Abstract]   [Full Text] [Related]  

  • 4. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
    Kirshenbaum JM; Bahr RD; Flaherty JT; Gurewich V; Levine HJ; Loscalzo J; Schumacher RR; Topol EJ; Wahr DW; Braunwald E
    Am J Cardiol; 1991 Dec; 68(17):1564-9. PubMed ID: 1746455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary urokinase and post-thrombolytic regimen in an infant with Kawasaki disease and acute myocardial infarction.
    Katayama F; Hiraishi S; Takeda N; Misawa H
    Heart; 1997 Dec; 78(6):621-2. PubMed ID: 9470886
    [No Abstract]   [Full Text] [Related]  

  • 9. Ridogrel as an adjunct to thrombolysis in acute myocardial infarction.
    van der Wieken LR; Simoons ML; Laarman GJ; Van den Brand M; Nijssen KM; Dellborg M; Hermens W; Vrolik W
    Int J Cardiol; 1995 Nov; 52(2):125-34. PubMed ID: 8749872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase infusion after unsuccessful angioplasty in patients with chronic total occlusion of native coronary arteries.
    Ceceña FA
    Cathet Cardiovasc Diagn; 1993 Mar; 28(3):214-8. PubMed ID: 8439996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
    Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ
    Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in coronary blood flow velocity during intracoronary thrombolysis and rescue coronary angioplasty for acute myocardial infarction.
    Flynn MS; Kern MJ; Aguirre FV; Bach RG; Caracciolo EA; Donohue TJ
    Cathet Cardiovasc Diagn; 1994 Mar; 31(3):219-24. PubMed ID: 8025940
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenge of maintaining coronary arterial patency with intravenous heparin following tissue plasminogen activator administration.
    Becker RC; Gore JM
    Cardiology; 1993; 83(1-2):100-6. PubMed ID: 8261475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty.
    Schächinger V; Kasper W; Zeiher AM
    Am J Cardiol; 1996 Jun; 77(14):1174-8. PubMed ID: 8651091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary thrombolytic agents and their characteristics].
    Yoshinaga M; Kambara H
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):775-81. PubMed ID: 12436615
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.
    Topol EJ; Califf RM; George BS; Kereiakes DJ; Rothbaum D; Candela RJ; Abbotsmith CW; Pinkerton CA; Stump DC; Collen D
    Circulation; 1988 May; 77(5):1100-7. PubMed ID: 2966017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct].
    Bruna C; Vado A; Rossetti G; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Uslenghi E
    G Ital Cardiol; 1997 Nov; 27(11):1144-52. PubMed ID: 9463058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.